3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Wilms Tumor
3
Rhabdomyosarcoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Sarcoma, Ewing
2
Plasmablastic Lymphoma
2
Neoplasms
2
Medulloblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Ganglioneuroblastoma
2
Down Syndrome
2
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroblastoma
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Interventions
Dexamethasone
2
Bortezomib
2
pomalidomide
1
isatuximab
1
fludarabine phosphate
1
elotuzumab
1
carfilzomib
1
belantamab mafodotin
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Vincristine
×
30 days
×
Clear all
No trials found.